Tafur, A. J., & Moore, E. D. (2022). Direct Oral Anti-Coagulants Continue to Bud into Gynecological Cancer-Thrombosis Prevention. Clinical and applied thrombosis/hemostasis, 28, 10760296221133792. https://doi.org/10.1177/10760296221133792
Chicago Style (17th ed.) CitationTafur, Alfonso J., and Elena Diaz Moore. "Direct Oral Anti-Coagulants Continue to Bud into Gynecological Cancer-Thrombosis Prevention." Clinical and Applied Thrombosis/hemostasis 28 (2022): 10760296221133792. https://doi.org/10.1177/10760296221133792.
MLA (9th ed.) CitationTafur, Alfonso J., and Elena Diaz Moore. "Direct Oral Anti-Coagulants Continue to Bud into Gynecological Cancer-Thrombosis Prevention." Clinical and Applied Thrombosis/hemostasis, vol. 28, 2022, p. 10760296221133792, https://doi.org/10.1177/10760296221133792.